Literature DB >> 174188

Characterization of a cobalamin-binding plasma protein from a patient with hepatoma.

E Nexö, H Olesen, J M Christensen, J Thomsen, K Kristiansen.   

Abstract

A cobalamin-binding protein has been purified by affinity chromatography from plasma of a patient with hepatoma and a 10,000-fold increase in the concentration of the plasma cobalamin-binding capacity. The protein behaved as normal transcobalamin I in gel filtration, agar gel electrophoresis, immunoelectrophoresis, precipitation by ammonium sulphate, and cobalamin-binding studies. The protein contained 38 per cent carbohydrate, and the relative molecular mass based on amino acid and carbohydrate analyses was 69,000. The molar absorption coefficient of cyanocobalamin bound to the protein was determined to be 36,000 at 362 nm. On amino acid sequencing, one amino terminal was found, and the first 13 residues were determined as Glu-Ile-Ser/Cys-Glu-Val-Ser/Cys-Glu-Glu-Asx-Tyr-Ile-Arg-Leu/Ile.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 174188     DOI: 10.1080/00365517509095798

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  3 in total

1.  High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma.

Authors:  F J Paradinas; W M Melia; M L Wilkinson; B Portmann; P J Johnson; I M Murray-Lyon; R Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-25

2.  Vitamin B12 binding protein as a tumour marker for hepatocellular carcinoma.

Authors:  S P Kane; I M Murray-Lyon; F J Paradinas; P J Johnson; R Williams; A H Orr; J Kohn
Journal:  Gut       Date:  1978-12       Impact factor: 23.059

3.  Comparison of recombinant human haptocorrin expressed in human embryonic kidney cells and native haptocorrin.

Authors:  Evelyne Furger; Sergey N Fedosov; Dorte Launholt Lildballe; Robert Waibel; Roger Schibli; Ebba Nexo; Eliane Fischer
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.